baber/WOPTO huggingface dataset:
Patent NZ-533856-A (NZ)
Title: Sulphated glycosaminoglycans with an anticoagulant activity of 100 BP units/mg or less for prophylactic priming or curative treatment of the cervix and myometrium during labour
Inventor: EKMAN-ORDEBERG GUNVOR
IPC: A61K38/095
Filed: 2003-01-02
Abstract: A method of treating protracted labor in a pregnant woman comprises administering to a pregnant woman an effective amount of a depolymerized low molecular weight heparin treated with periodate to eradicate antithrombin III binding affinities, thereby exhibiting an anticoagulant activity of 10 BP units/mg or less and an average molecular weight not higher than 10000 Da to prime or curatively treat the cervix and myometrium and for treatment of slow progress of labor. A method for prophylactic priming or curative treatment of the cervix and the myometrium for establishing effective labor in a pregnant woman comprises administering to a pregnant woman an effective amount of a depolymerized low molecular weight heparin as described to prophylactically prime or curatively treat the cervix and myometrium and for establishing effective labor in the pregnant woman.
Patent NZ-534614-A (NZ)
Title: Heat pump type air conditioner with parallel capillary and/or expansion valves
Inventor: GU CHUJUN
IPC: F25B41/06
Filed: 2002-06-26
Abstract: Disclosed is a heat pump type air conditioner. The air conditioner includes a compressor, an outdoor heat exchanger, an indoor exchanger, and a four way change valve, which characterized in that it further includes capillaries in parallel, expansion valves in parallel or an apparatus combined by a capillary and an expansion valve in parallel, in which the capillaries in parallel, the expansion valves in parallel and their combined apparatus of which are connected to the indoor heat exchanger and the outdoor heat exchanger respective. Said capillaries in parallel, expansion valves in parallel or said combined apparatus consist of a three-way valve or two one way valve in opposite pass direction, and two capillaries in parallel, two expansion valves in parallel, a capillary and an expansion valve in parallel, or an apparatus combined by two capillaries and two expansion in series. It is stated that the present invention provides a new heat pump type air conditioner having new structure, excellent property and high efficiency.
Patent NZ-537302-A (NZ)
Title: Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
Inventor: JAEHNE GERHARD
Filed: 2003-06-04
Abstract: Disclosed are compounds of formula (I), wherein: At least one of R1 to R6 must have the meaning (C0 - C30)-alkylene-(LAG)n, where (LAG)n is -(CH2)1-10-SO3H, -(CH2)0-10-P(O)(OH)2, -(CH2)0-10-O-P(O)(OH)2, -(CH2)0-10-COOH and n may be 1-5. Further disclosed is the use of the compounds of formula (I), optionally in combination with one or more other active ingredients, in the manufacture of a medicament for the treatment of hyperlipidemia.
Patent NZ-538341-A (NZ)
Title: Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders
Inventor: WERMUTH CAMILLE GEORGES
IPC: A61P25/16
Filed: 2003-08-18
Abstract: Disclosed are pamoate salts of a 3-phenyl-3-dimethylaminoalkyl-4,4-dimethylpiperidin-2,6-dione of formula I wherein: R1 represents methoxy, ethoxy or hydroxyl; R2 represents methoxy, ethoxy, hydroxyl or hydrogen; and n represents 2,3. Salts of the type disclosed are useful in the treatment of stress-related affective disorders.
Patent NZ-539147-A (NZ)
Title: Boat propulsion system with trim plate in channel to control water flow to propeller
Inventor: NOYES EVAN L
IPC: B63H5/16
Filed: 2001-10-05
Abstract: A boat propulsion system includes a boat having an elongated hull (154) with a water flow channel (156A, 156B) formed in the bottom thereof, wherein a movable trim plate (178A, 178B) is disposed within the water flow channel (156A, 156B) for controlling a flow of water to a surface-piercing propeller (not shown) which is positioned aft of the water flow channel (156A, 156B) and which is disposed within a propeller cavity (170) formed in the bottom of the hull (154). In a fully extended position, the trim plate (178A, 178B) is flush with the hull of the boat, and in fully recessed position the trim plate (178A, 178B) is completely recessed within the water flow channel (156A, 156B). The trim plate (178A, 178B) is variably movable between the recessed and fully extended positions to provide for performance advantages at various boat speeds.
Patent NZ-543732-A (NZ)
Title: Aspirating apparatus with ring duct in toilet bowl front and side walls connected to outlet pipe of toilet flush box
Inventor: MATTIELLO RUGGERO
IPC: E03D9/05
Filed: 2004-04-23
Abstract: Disclosed is an aspirating apparatus particularly for toilets (10). This apparatus comprises an aspirator (11), operationally in the inlet connected to the outlet pipe (12) from the flush box (13) of a toilet bowl (14) and in the outlet to the outside of the bathroom or the toilet housing the toilet bowl (14). In one of the embodiments this aspirator (11) is operationally connected in the outlet to the part of the outfall sewer conduit (16) of the toilet bowl (14) placed downstream the siphon (17) of same bowl (14). In this embodiment the apparatus (10) comprises furthermore flow interception means (18) placed between this part of the outfall sewer conduit (16) of the toilet bowl (14) and the outlet pipe (12) from the flush box (13).
Patent NZ-545443-A (NZ)
Title: Combination of an aclidinium salt known as 3-(2-hydroxy-2,2-dithiophen-2-yl-acetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane and a steroid and its use to treat respiratory disorders by inhalation
Inventor: PAIRET MICHEL
IPC: A61K31/4745
Filed: 2004-07-17
Abstract: The disclosure relates to a pharmaceutical composition which includes one or more salts of anticholinergenic agent of formula 1 wherein X - denotes bromide optionally in the form of a racemate, a enantiomer, and a hydrate thereof, combined with the steroid budesonide, optionally in the form of an enantiomer, mixtures of enantiomers, a racemate, a solvate or a hydrate, and optionally together with a pharmaceutically acceptable excipient. Also disclosed is the use of the pharmaceutical composition in preparing a medicament for the treatment of an inflammatory or obstructive respiratory condition.
Patent NZ-547217-A (NZ)
Title: Autoclaved aqueous suspensions of ciclesonide for nebulisation
Inventor: BRUECK-SCHEFFLER ANTJE
IPC: C07J71/00
Filed: 2004-12-15
Abstract: This disclosure relates to a method for the preparation of sterile aqueous suspensions of ciclesonide by sterilization with moist heat. The dislcosure further relates to pharmaceutical compositions in particular to sterile aqueous suspensions of ciclesonide for administration by nebulization in the prophylaxis and/or treatment of respiratory diseases.
Patent NZ-547840-A (NZ)
Title: Retractable shade for coverings for architectural openings
Inventor: JELIC RALPH G
IPC: E06B9/34
Filed: 2004-12-21
Abstract: A fabric 36 for use in a covering 32 for a building structure comprising in combination a flexible support structure, and a plurality of parallel elongated vanes 42 supported at spaced locations along the support structure, the parallel elongated vanes 42 are all attached to the exterior of the support structure to move in response to movement of the support structure and project from the front of the support structure when the fabric 36 is moved to a retracted position.
Patent NZ-551858-A (NZ)
Title: Valve of poppet-type with stem having piston on distal end within cylinder fixed relative to valve seat
Inventor: MCCAUSLAND ANDREW JOHN
IPC: B01D29/66
Filed: 2002-12-18
Abstract: Disclosed is a valve of the poppet-type with stem having a piston on its distal end within cylinder fixed relative to valve seat.
Patent NZ-551928-A (NZ)
Title: Exchange traded contracts for difference
Inventor: CHAPMAN KEN
Filed: 2006-12-11
Abstract: A computer system for performing a method of managing an Exchange traded contract for difference (CFD) is disclosed. The CFD is created between short position holders and long position holders and is based on an underlying security. The method involves the steps of receiving interest from the long position holders and paying this to the short position holders, receiving dividends from the short position holders and paying these to the long position holders, receiving franking credits paid by the short position holders, and paying the franking credits paid by short position holders which are not pre-appointed market makers to the long position holders.
Patent NZ-552784-A (NZ)
Title: A base for a road sign including collapsible legs with skids
Inventor: BREWIN PAUL GREGORY
Filed: 2007-01-23
Abstract: A signage base 1, for supporting a road sign, comprises a hub 2 and hub dependent legs 4. In a deployed condition, the legs 4 support the hub 2 in an upright position. At least one of the legs has a distal skid 5 that facilitates sliding into a tipped over condition, where some of the legs 4 are no longer deployed such that the base 1 does not project upwards from the ground to a height of more than 150mm.
Patent NZ-566022-A (NZ)
Title: Caspase inhibitor prodrugs
Inventor: DURRANT STEVEN
IPC: A61K31/429
Filed: 2006-07-20
Abstract: The disclosure relates to prodrugs of caspase inhibitors of formula (I) comprising of a furo[3, 2-d]oxazolin-5-one moiety which, under specific conditions, can convert into biologically active compounds, particularly caspase inhibitors. This disclosure also relates to the processes for preparing these prodrugs of caspase inhibitors of formula (I). The disclosure further relates to pharmaceutical compositions comprising said prodrugs and to the use thereof for the treatment of diseases related to inflammatory or degenerative conditions.
Patent NZ-567298-A (NZ)
Title: Handle latching mechanism
Inventor: MADDISON IAN
Filed: 2008-04-10
Abstract: A power tool comprising: at least a pair of handles (10, 20), wherein each of the pair of handles has (a) a respective actuator (14, 24) for operating the power tool; and (b) a respective guard member (16, 26) for restricting access to the respective actuator; the power tool further comprising a latch mechanism (72, 74) for latching the pair of handles together, wherein the latch mechanism has a first component (72) mounted on a first one (16) of the guard members and a second component (74) mounted on a second one (26) of the guard members and adapted to engage with the first component. Thus, the components of the latch mechanism are mounted on the respective guard members for the actuators, rather than directly on the handles themselves. This ensures that the components of the latch mechanism are able to latch the handles together without being impeded by the presence of the guard members or the actuators. In a preferred embodiment, the latch mechanism further comprises user-operable means (72a, 72f) for holding the latch mechanism both in a latched condition and in an unlatched condition but not otherwise, such that the latch mechanism has only a first stable configuration which is the latched condition and a second stable configuration which is the unlatched condition. This ensures that the handles can be latched together as desired by the user, but without becoming latched together accidentally at unwanted times or alternatively becoming unlatched accidentally.
Patent NZ-577120-A (NZ)
Title: Wind power generation using flow channel with sections including acclerators
Inventor: REITZ GEORG
IPC: B60L50/10
Filed: 2007-10-26
Abstract: Disclosed is a wind power installation (1) for generating electric power from moving ambient air. The installation comprises an external sleeve which forms the boundary of a flow channel (3) through which the air is conducted. The channel (3) has a first section (7) into which the ambient air can be introduced. This section (7) has an essentially constant cross section and is provided with an air acceleration device (39). The channel also has a second, tapering section (9) which is followed by a third section (11). A rotor (25) is installed in the third section (11) and is set in motion by air flowing through the channel (3). The motion of the rotor (25) is used to generate electric power. A fourth, enlarging section (13) is also provided and is followed by a fifth section (15). The fifth section (15) comprises a second air acceleration device (85) to discharge the air from the flow channel (3).
Patent NZ-577339-A (NZ)
Title: Heating and cooling system
Inventor: OATEN TERRENCE R
IPC: F24S90/00
Filed: 2007-12-11
Abstract: An integrated heating and cooling system for a living space of a building that can achieve and/or maintain a desired temperature in the living space is disclosed. The integrated heating and cooling system includes (a) a solar-based heating and cooling system; (b) a heating and cooling system that relies directly or indirectly on fossils fuels and (c) a controller. The solar-based heating and cooling system includes a roof assembly that includes a roof, a roof space in heat exchange relationship with at least a section of the roof, and a chamber that includes (i) one or more than one inlet for airflow from the roof space into the chamber, (ii) one or more than one first opening for airflow from the roof space to the chamber to outside the building altogether to cool the building in "summer" conditions, and (iii) one or more than one second opening for airflow from the roof space via the chamber to a living space of the building to heat the living space in "winter" conditions and to cool the living space in "nocturnal" conditions. The controller firstly operates the solar-based heating and cooling system to heat and/or cool the living space and, if required, thereafter operates the fossil fuel-based heating and cooling system to heat and/or cool the living space, to achieve and/or to maintain the temperature in the living space at the desired temperature.
Patent NZ-581935-A (NZ)
Title: Biometric authentication for video communication sessions
IPC: H04L12/18
Filed: 2009-12-14
Abstract: A method and an apparatus for authenticating a video communication sessions are disclosed. The apparatus comprises at least one processor configured to scan a biometric parameter; determine if the scanned biometric parameter matches at least one of a plurality of biometric parameters within a database and if no match exists in the database then the scanned biometric parameter is added to the database; determine whether an individual associated with the scanned biometric parameter is authorized to participate in a video conference; if the individual is authorized then the individual is connected to the video conference; generate a tag (701b) for the individual at the video conference; and output to a video conferencing screen, the tag for the individual.
Patent NZ-583625-A (NZ)
Title: Method for producing mineral-bearing cover layers for floor coverings comprising a polyurethane reaction mixture comprising hydroxyl functional compounds having hydrophobic groups and isocyanates
Inventor: MOHMEYER NILS
IPC: C04B26/16
Filed: 2008-09-12
Abstract: Disclosed is a process for the production of top layers for roads, tracks, and other areas used by traffic, by producing a mixture comprising mineral material and a polyurethane reaction mixture, and also, if appropriate, further additions, applying it to a substrate material, and compacting and hardening it by applying a pressure of at least 5 N/cm2, where operations are substantially carried out without use of solvents and the polyurethane reaction mixture is obtained by mixing of: a) isocyanates with b) compounds having at least two hydrogen atoms reactive toward isocyanate, which comprise a hydroxy-functional compound having hydrophobic groups, and also, if appropriate, c) chain extenders and/or crosslinking agents, d) catalysts, and e) other additives.
Patent NZ-588843-A (NZ)
Title: Dpp-iv inhibitors for use in the treatment of non-alcoholic fatty liver disease
Inventor: KLEIN THOMAS
IPC: A61K31/40
Filed: 2009-06-02
Abstract: Disclosed is the use of a DPP-4 inhibitor of either formulae I to IV (xanthines, piperidinones, and piperazinones) sitagliptin, (3R)-3-amino-1-[3-2S-(trifluoromethyl)-5,6,7,8-tetrahydro-5H-[1,2,4 ]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one, vildagliptin, (2S)-{ [(3-hydroxyadamantan-1-yl)amino]acetyl} pyrrolidine-2-carbonitrile, saxagliptin, (1S,3S,5S)-2-{ (2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl} -2-azabicyclo[3.1.0]hexane-3-carbonitrile, alogliptin, 2-({ 6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl} methyl)benzonitriIe, or (2S)-1-{ [2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethylamino]-acetyl} -pyrrolidine-2-carbonitrile, (2S)-1-{ [1,1,-Dimethyl-3-(4-pyridin-3-yl-imidazol-1-yl)-propylamino]-acetyl} pyrrolidine-2-carbonitrile, (S)-1-((2S,3S,11bS)-2-Amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one, (3,3-Difluoropyrrolidin-1-yl)-((2S,4S)-4-(4-(pyrimidin-2-yl)piperazin-1-yl)pyrrolidin-2-yl)methanone, (1((3S,4S)-4-amino-1-(4-(3,3-difluoropyrrolidin-1-yl)-1,3,5-triazin-2-yl)pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one, (2S,4S)-1-{ 2-[(3S,1R)-3-(1H-1,2,4-Triazol-1-ylmethyl)cyclopentylamino]-acetyl} -4-fluoropyrrolidine-2-carbonitrile, (R)-2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile, or 5-{ (S)-2-[2-((S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-propyl} -5-(1H-tetrazol-5-yl)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene-2,8-dicarboxylic acid bis-dimethylamide in the manufacture of a medicament for the treatment or prevention of non-alcoholic fatty liver disease (NAFLD), including hepatic steatosis, non-alcoholic steatohepatitis and liver fibrosis.
Patent NZ-595358-A (NZ)
Title: Building unit structural member and floor structure utilizing said unit structural member
Inventor: SAWADA TAIICHI
IPC: E04B5/02
Filed: 2010-02-19
Abstract: 595358 Disclosed is unit structural member (20) for forming a floor structure. The structural member comprises a pair or longitudinal beams (15) arranged in parallel, having a number of shorter lateral beams (16) arranged in parallel between the longitudinal beams. Both the longitudinal and lateral beams are formed from M-shaped metal channel, which provides the advantage of simplification, homogenisation and cost reduction in the construction of a building. The M-shaped channel is constituted by a centre U-shaped channel, having mutually opposite facing U-shaped channels formed either side of the centre U-shaped channel. A diagonally oriented beam (see 17, figure 4) may also be located between the longitudinal beams. A floor structure, formed from multiple unit structural members, is also disclosed.
Patent NZ-597359-A (NZ)
Title: Emergency interventions of active charcoal with dabigatran etexilate overdosing
Inventor: VAN RYN JOANNE
IPC: A61P39/00
Filed: 2010-08-23
Abstract: 597359 The disclosure relates to the use of active charcoal for the manufacture of a medicament for the treatment of an overdose of dabigatran etexilate (formula I). The medicament may be formulated for oral administration with 20 – 130 g of charcoal. The disclosure also relates to the use of charcoal for the manufacture of a medicament for absorbing dabigatran from blood plasma.
Patent NZ-599082-A (NZ)
Title: Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same
Inventor: MEDASANI MUNISEKHAR
IPC: A01N33/08
Filed: 2010-09-02
Abstract: Disclosed herein is a therapeutic composition for prevention, elimination, treatment and management of neurodegenerative and neuro-muscular degenerative disorders and diseases in human and animal subjects, such as Amytrophic lateral sclerosis (ALS), Multiple sclerosis (MS), Alzheimer’s disease (AD), Parkinson’s disease (PD), and Muscular dystrophy (MD) and others, wherein the composition comprises a first component and a second component, said first component being mannitol in any of the forms thereof, or any of the mixtures of said forms, and said second component being ascorbic acid in any of the forms thereof such as the oxidised form, the reduced form, the mineral ascorbates, the fatty acid esters of ascorbic acid and others, or any of the mixtures of said forms. and further comprising zinc citrate, the composition being in any one of the following forms: (a) an intravenous(IV) fluid and the composition thereof is mannitol from about 1.8% w/v to about 25% w/v, zinc citrate from about 0.01% w/v to about 0.2% w/v and ascorbic acid from about 0.1% w/v to about 5% w/v, water qs, preservative qs, potassium phosphate buffer 7.4 pH, in about 100 ml of the said fluid and pro rata for other volumes; (b) a syrup for oral administration, and comprising mannitol from about 5g to about 15g, ascorbic acid from about 5 g to about 12g and zinc citrate from about 120 mg to about 500 mg in about 30 ml of the said syrup and pro rata for other volumes, said composition further comprising BHT, ethyl alcohol, water, colouring agent, flavoring agent, pH adjusters, purified water as necessary; (c) a solution suitable for intramuscular administration, said solution comprising mannitol from about 500 mg to about 1000 mg, ascorbic acid from about 250 mg to about 2000 mg, zinc citrate from about 10 mg to about 100 mg, water qs, benzyl alcohol preservative and sodium hydroxide and hydrochloric acid for pH adjustment in about 10 ml of the solution and pro rata for other volumes; (d) a nasal spray and comprises mannitol from about 100 mg to about 500mg, zinc citrate from about 2 mg to about 15mg, dehydroascorbic acid from about 200 mg to about 500mg, in about 30 ml of the spray solution and pro rata for other volumes, said composition further comprising citric acid, sodium citrate, glycerin and benzalkonium chloride as necessary; and (e) a transdermal patch known to the art comprises mannitol from about 500 mg to about 1000 mg, zinc citrate from about 15 mg to about 75mg, ascorbic acid from about 500 mg to about 2000 mg, absorbent gel qs and preservative qs, and pro rata for larger patches.
Patent NZ-603028-A (NZ)
Title: Tfpi inhibitors and methods of use
Inventor: OSTERKAMP FRANK
IPC: A61K38/18
Filed: 2011-02-11
Abstract: Disclosed is a peptide comprising: (i) an amino acid sequence selected from the group consisting of SEQ ID NOs: 4133, 4137, 4153-4155, and 4158; (ii) an amino acid sequence having at least 90% identity to the sequence of (i); or (iii) an amino acid sequence comprising one or two substitution(s), deletion(s) or insertion(s) of amino acid(s) in the sequence of (i) or (ii); wherein the sequences are as defined in the specification. Also disclosed is its use in the preparation of a medicament for treating a subject suffering from a blood coagulation disorder or at risk of suffering from a blood coagulation disorder.
Patent NZ-603546-A (NZ)
Title: Yeast production culture for the production of butanol
Inventor: NAGARAJAN VASANTHA
IPC: C12R1/865
Filed: 2011-06-16
Abstract: Disclosed is a production culture for the fermentative production of butanol comprising: (i) a medium comprising a fermentable carbon substrate; (ii) a culture of butanol producing yeast cells comprising a butanol biosynthetic pathway and having a cell density of at least about 2.4 gram dry cell weight per litre; and (iii) butanol produced by the butanol producing yeast cells at a concentration of at least about 2% (w/v) in the medium.